Skip to main content

Table 5 Venous thromboembolism risk factors

From: Outcomes of tranexamic acid administration in military trauma patients with intracranial hemorrhage: a cohort study

 Total (n = 71)VTE (n = 9)No VTE (n = 62)P-value
ISS28.2 ± 12.340.3 ± 10.726.4 ± 11.50.001*
Lower extremity amputation, n6 (8.5%)2 (22.2%)4 (6.5%)0.16
Lower extremity fracture, n21 (29.6%)6 (66.7%)15 (24.1%)0.02*
Pelvic fracture, n3 (4.2%)2 (22.2%)1 (1.6%)0.04*
Spinal cord injury, n4 (5.6%)1 (11.1%)3 (4.8%)0.43
Ventilator days6.5 ± 6.512.1 ± 5.25.7 ± 6.30.004*
Blood products transfused (units)17.3 ± 28.244.2 ± 49.113.4 ± 21.80.008*
Received massive transfusion within 24 h, n9 (12.7%)3 (33.3%)6 (9.7%)0.08
Administered recombinant Factor VII, n1 (1.4%)0 (0%)1 (1.6%)1.0
Administered TXA, n14 (19.7%)5 (55.6%)9 (14.5%)0.01*